Looking Beyond Fatty Liver

New evidence highlights the importance of considering LIPA variants in fatty liver disease

A new study from the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) investigated the frequency and significance of rare LIPA variants associated with Lysosomal Acid Lipase Deficiency (LAL-D) in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).

The study reflects growing recognition within the hepatology community that genetic causes of liver disease, including LAL-D, should be considered when evaluating patients with steatotic liver disease. Identifying pathogenic variants in LIPA may have important implications for diagnosis, clinical management, and long-term follow-up.

For the LAL-D community, research like this is particularly valuable because it helps raise awareness of the potential overlap between rare inherited liver disorders and more common liver conditions, reinforcing the need for accurate diagnosis and appropriate genetic evaluation.

👏 Congratulations to Chaowapong Jarasvaraparn, David E. Kleiner, Katherine P. Yates, Callie Zaberenko, Jean P. Molleston, and colleagues for advancing our understanding of the role of LIPA variants in liver disease.

Every step toward improving recognition of LAL-D helps shorten the diagnostic journey for patients and families.